7 Results for "

HIT-T15

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "HIT-T15" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-15564
CAS No.: 733750-99-7
Purity:  99.58%
Target:  

GPR119

Research Areas:  

Metabolic Disease

AR 231453 is a potent, specific and orally available GPR119 agonist. AR 231453 can stimulate β-cell replication and improve islet graft function s .
loading...
    loading...
Cat. No.: HY-108448
CAS No.: 105955-11-1
Purity:  99.47%
Synonyms: OLDA
N-Oleoyldopamine (OLDA) is an orally active TRPV1 activator and 5-LOX inhibitor with blood-brain barrier permeability. N-Oleoyldopamine excites histaminergic neurons in the tuberomammillary nucleus via a dopamine receptor mechanism, a process independent of TRPV1 and cannabinoid receptors. On one hand, N-Oleoyldopamine promotes the release of insulin and glucose-dependent insulinotropic polypeptide through a GPR119-dependent pathway to improve glucose tolerance; on the other hand, N-Oleoyldopamine improves left ventricular function and reduces myocardial infarction size by triggering the release of substance P and calcitonin gene-related peptide. N-Oleoyldopamine is used in studies related to glycemic abnormalities and myocardial ischemia-reperfusion injury .
loading...
    loading...
Cat. No.: HY-120962
CAS No.: 119959-65-8
Purity:  ≥99.0%
Target:  

TRP Channel

Research Areas:  

Metabolic Disease

N-Arachidonoyl Taurine is an activator of the transient receptor potential vanilloid TRPV1 and TRPV4, with EC50s value of 28 μM and 21 μM, respectively .
loading...
    loading...
Cat. No.: HY-178780
CAS No.: 2137977-29-6
Synonyms: MKP10241
Target:  

GPR119

Deziglipel (MKP10241) is an orally active GPR119 agonist (human EC50: 3.7 nM; IC50 > 7.2 μM). Deziglipel activates GPR119 to increase cAMP levels, promotes active GLP-1 release, reduces blood glucose and HbA1c, decreases body weight and feed intake, and resolves MASH via altered lipid, cytokine, and liver enzyme levels. Deziglipel shows low hERG channel inhibition, minimal CYP450 inhibition, no PXR activation, and no significant transporter inhibition. Deziglipel can be used for the research of type 2 diabetes mellitus, obesity, MASH/MASLD, and metabolic disorders .
loading...
    loading...
Cat. No.: HY-15564R
CAS No.: 733750-99-7
Target:  

GPR119

Research Areas:  

Metabolic Disease

AR 231453 (Standard) is the analytical standard of AR 231453. This product is intended for research and analytical applications. AR 231453 is a potent, specific and orally available GPR119 agonist. AR 231453 can stimulate β-cell replication and improve islet graft function s .
loading...
    loading...
Cat. No.: HY-155553
CAS No.: 1384951-03-4
Target:  

GPR119

Research Areas:  

Metabolic Disease

GPR119 agonist 2 (compound 43) is an orally active GPR119 agonist. GPR119 agonist 2 shows good pharmacokinetic characteristics in rodents and can effectively improve glucose tolerance in mice and rats. GPR119 agonist 2 has the potential to study type 2 diabetes .
loading...
    loading...
Cat. No.: HY-108448R
CAS No.: 105955-11-1
Synonyms: OLDA (Standard)
N-Oleoyldopamine (Standard) is the analytical standard of N-Oleoyldopamine (HY-108448). This product is intended for research and analytical applications. N-Oleoyldopamine (OLDA) is a product of condensation of oleic acid and dopamine (DA) and an endogenous TRPV1 selective agonist. N-Oleoyldopamine (OLDA) can crosses the blood-brain barrier. N-oleoyl-dopamine protects the heart against ischemia-reperfusion injury via activation of TRPV1 .
loading...
    loading...